Delivery Order SPE2DB20D9331-SPE2DB25FL1E1

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,250.73 contract is for the delivery of 4,567,951,594 units of Atovaquone-Proguanil 250-100 100s, a prescription medication. The contract has an ultimate completion date of April 18, 2025 and was awarded on April 17, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $2,067.00 and has a completion date of June 26, 2024. DMS Pharmaceutical Group will supply the DLA with 4564993076 units of Atovaquone-Proguanil 250-100mg tablets. This delivery order is issued under a larger indefinite delivery...
This is a Delivery Order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,332.80 Firm Fixed Price contract is for the delivery of Atovaquone 250mg/Proguanil HCl 100mg tablets, with a period of performance through June 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $499,999,999 that DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,513.23, is for the delivery of the pharmaceutical product ATOVAQUONE/PROGUANIL and has a completion date of May 22, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,499.52 contract is for the delivery of 4558986658 - ATOVAQUONE-PROGUANIL 250-100 100S, a specialized pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA, which covers a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of Atovaquone-Proguanil 250-100mg tablets. The contract has a completion date of February 14, 2024 and a potential value of $1,929.20. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDV) 4600082013 with the Defense Logistics Agency, valued at up to...
This is a $1,405.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for the delivery of atovaquone/proguanil, a prescription anti-malarial medication, to support the medical supply needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,612.71, is for the delivery of ATOVAQUONE-PROGUANIL 250-100 100S medication. It is a firm fixed-price contract with no set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,314.00 contract is for the delivery of Atovaquone-Proguanil 250-100 mg tablets, a malaria treatment medication, with a completion date of January 26, 2024. This delivery order falls under DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $3,810.60 firm fixed-price contract is for the delivery of Atovaquone-Proguanil 250-100 tablets. The contract has no set-aside designation and is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24D9131 with the DLA, which has a ceiling value of up to $4,999,999 through 2025. This indefinite delivery vehicle enables the...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB25FL1E1
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,111.76, is for the delivery of 4,568,118,586 units of Atovaquone-Proguanil 250-100 100S, a prescription medication. The contract has a period of performance through May 5, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This contract was awarded without any set-aside designation.

Generated 8/3/25, 12:59 AM